Our research interest lies at the interface of chemistry and biology, in the study and development of metallocomplexes for targeted cancer therapy. Our work focuses mainly on Pt- and Ru-based complexes as non-classical therapeutic agents and elucidating their modes of action. We are also actively pursuing fluorescence probes that would allow us to investigate these compounds in live cell models. Our 4 broad areas of research are:

1) Developing the chemistry of platinum(IV) carboxylates as anticancer prodrug complexes

2) Fluorescence probes for the investigation of cisplatin and its parent platinum(IV) prodrug complexes

3) Metallocomplexes as Immuno-Chemotherapeutic agents